MedPath

COOL-Trial: Outcome With Invasive and Non-invasive Cooling After Cardiac Arrest

Phase 4
Completed
Conditions
Hypothermia
Cardiac Arrest
Registration Number
NCT00843297
Lead Sponsor
University of Leipzig
Brief Summary

Sudden cardiac arrest (SCA) remains one of the major leading causes of death. Cognitive deficits are common in survivors of SCA. Postresuscitative mild induced hypothermia (MIH) lowers mortality and reduces neurologic damage after cardiac arrest. The investigators evaluated the efficacy and side effects of therapeutic hypothermia in an unselected group of patients after SCA.

Detailed Description

Consecutive patients with restoration of spontaneous circulation (ROSC) after resuscitation due to out-of-hospital SCA, admitted to our intensive care unit, underwent MIH. Hypothermia was induced by infusion of cold saline and whole-body-cooling methods (electronic randomization: invasive Coolgard or non-invasive ArcticSun). The core body temperature was operated at 32 to 34 °C over a period of 24 hours followed by active rewarming. Neurological status was evaluated at hospital discharge and 6 months after discharge using the Pittsburgh Cerebral Performance Category (CPC). Blood samples of neuron-specific enolase (NSE) were collected during 72 hours.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
120
Inclusion Criteria
  • ROSC after SCA due to VF/VT or PEA/Asystolia
  • GCS 3
Exclusion Criteria
  • Non-cardiac SCA
  • Pregnancy
  • Unstable Circulation instead of High-dose Inotropics
  • Life-expectancy reducing concomitant illness

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Time to reach the target temperatureTwenty-four hours
NSE as a parameter for cerebral damageSeventy-two hours
Secondary Outcome Measures
NameTimeMethod
Periprocedural complicationsSeventy-two hours
SurvivalSix months
Neurologic outcomeSix months

Trial Locations

Locations (1)

University of Leipzig, Heart Center, Cardiology

🇩🇪

Leipzig, Germany

University of Leipzig, Heart Center, Cardiology
🇩🇪Leipzig, Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.